Article

FDA clears SD-OCT floor stand

The FDA has granted 510(k) clearance to a new multi-directional rolling floor stand (iStand, Optovue) for universal positioning of a compact spectral domain optical coherence tomography (SD-OCT) device (iVue, Optovue).

Fremont, CA-The FDA has granted 510(k) clearance to a new multi-directional rolling floor stand (iStand, Optovue) for universal positioning of a compact spectral-domain optical coherence tomography (SD-OCT) device (iVue, Optovue).

The system enables eye-care professionals to follow patients from diagnosis through postoperative care. The stand is designed to expand the clinical utility of the SD-OCT device to enhance clinical decision-making, procedure planning, and documentation. By mounting the SD-OCT device onto the floor stand, clinicians can move the system between the exam lanes, hospital facilities, and satellite offices. The stand’s articulating arm is designed to facilitate scanning in the supine and other positions.

“The additional knowledge provided by the [SD-OCT] with [the stand] enhances control over procedural variability, resulting in greater predictability of results, and potentially reducing the rate of re-operations,” said Nalin Mehta, MD, who is in private practice at the Colorado Retina Center, Denver. Dr. Mehta said he has evaluated the system and found it useful in assessing the macula for epiretinal membranes, macular holes, and subclinical choroidal effusions.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.